These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7799495)

  • 21. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening mammography and public health policy: the need for perspective.
    Wright CJ; Mueller CB
    Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammography utilization, public health impact, and cost-effectiveness in the United States.
    White E; Urban N; Taylor V
    Annu Rev Public Health; 1993; 14():605-33. PubMed ID: 8323604
    [No Abstract]   [Full Text] [Related]  

  • 24. Early detection of breast cancer in women.
    Humphrey LL; Ballard DJ
    Prim Care; 1989 Mar; 16(1):115-32. PubMed ID: 2495540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
    Burnside E; Belkora J; Esserman L
    Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.
    Leivo T; Sintonen H; Tuominen R; Hakama M; Pukkala E; Heinonen OP
    Cancer; 1999 Aug; 86(4):638-46. PubMed ID: 10440691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of screening mammography in the Veterans Health Administration: implications for breast cancer treatment.
    Kvasnovsky CL; Kesmodel SB; Gragasin JL; Punnoose V; Johnson PA; Goel R; Reddy SK; Pierson RN; Jain A
    JAMA Surg; 2013 Nov; 148(11):999-1004. PubMed ID: 24048217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammographic screening for breast cancer: An invited review of the benefits and costs.
    Greif JM
    Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic considerations in breast cancer screening of older women.
    Brown ML
    J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 35. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.
    Mandelblatt J; Saha S; Teutsch S; Hoerger T; Siu AL; Atkins D; Klein J; Helfand M;
    Ann Intern Med; 2003 Nov; 139(10):835-42. PubMed ID: 14623621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening younger women at risk for breast cancer.
    Vogel VG
    J Natl Cancer Inst Monogr; 1994; (16):55-60. PubMed ID: 7999470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings.
    Warren JL; Brown ML; Fay MP; Schussler N; Potosky AL; Riley GF
    J Clin Oncol; 2002 Jan; 20(1):307-16. PubMed ID: 11773184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.